Literature DB >> 17713652

Cytotoxic and DNA-topoisomerase effects of lapachol amine derivatives and interactions with DNA.

A Esteves-Souza1, D V Figueiredo, A Esteves, C A Câmara, M D Vargas, A C Pinto, A Echevarria.   

Abstract

The cytotoxic activity of amino (3a-e), aza-1-antraquinone (4a-e) lapachol derivatives against Ehrlich carcinoma and human K562 leukemia cells was investigated. Cell viability was determined using MTT assay, after 48 (Ehrlich) or 96 h (K562) of culture, and vincristine (for K562 leukemia) and quercetin (for Ehrlich carcinoma) were used as positive controls. The results showed dose-dependent growth-inhibiting activities and that the amino derivatives were active against the assayed cells, whereas the 4a-e derivatives were not. The allylamine derivative 3a was the most active against Ehrlich carcinoma, with IC50 = 16.94 +/- 1.25 microM, and against K562 leukemia, with IC50 = 14.11 +/- 1.39 microM. The analogous lawsone derivative, 5a, was also active against Ehrlich carcinoma (IC50 = 23.89 +/- 2.3 microM), although the 5d and 5e derivatives showed lower activity. The interaction between 3a-d and calf thymus DNA was investigated by fluorimetric titration and the results showed a hyperchromic effect indicating binding to DNA as presented of ethidium bromide, used as positive control. The inhibitory action on DNA-topoisomerase II-a was also evaluated by a relaxation assay of supercoiled DNA plasmid, and the etoposide (200 microM) was used as positive control. Significant inhibitory activities were observed for 3a-d at 200 microM and a partial inhibitory action was observed for lapachol and methoxylapachol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713652     DOI: 10.1590/s0100-879x2006005000159

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  7 in total

1.  Characterization of lapachol cytotoxicity: contribution of glutathione depletion for oxidative stress in Saccharomyces cerevisiae.

Authors:  Frederico A V Castro; Gabriel F M de Souza; Marcos D Pereira
Journal:  Folia Microbiol (Praha)       Date:  2019-06-11       Impact factor: 2.099

2.  Encapsulation of nor-β-lapachone into poly(d,l)-lactide-co-glycolide (PLGA) microcapsules: full characterization, computational details and cytotoxic activity against human cancer cell lines.

Authors:  Marcília P Costa; Anderson C S Feitosa; Fátima C E Oliveira; Bruno C Cavalcanti; Gleiston G Dias; Ewerton W S Caetano; Francisco A M Sales; Valder N Freire; Stefano Di Fiore; Rainer Fischer; Luiz O Ladeira; Eufrânio N da Silva Júnior; Claudia Pessoa
Journal:  Medchemcomm       Date:  2017-09-07       Impact factor: 3.597

3.  Genotoxicity of lapachol evaluated by wing spot test of Drosophila melanogaster.

Authors:  Wender Ferreira Costa; Alaide Braga de Oliveira; Júlio César Nepomuceno
Journal:  Genet Mol Biol       Date:  2010-09-01       Impact factor: 1.771

4.  Inhibitory effects of lapachol on rat C6 glioma in vitro and in vivo by targeting DNA topoisomerase I and topoisomerase II.

Authors:  Huanli Xu; Qunying Chen; Hong Wang; Pingxiang Xu; Ru Yuan; Xiaorong Li; Lu Bai; Ming Xue
Journal:  J Exp Clin Cancer Res       Date:  2016-11-16

5.  Synthesis and pharmacological activity of diterpenylnaphthoquinone derivatives.

Authors:  Mariano Walter Pertino; Cristina Theoduloz; Jose Antonio Palenzuela; Maria del Mar Afonso; Erdem Yesilada; Francisco Monsalve; Paulo González; Daniel Droguett; Guillermo Schmeda-Hirschmann
Journal:  Molecules       Date:  2011-10-13       Impact factor: 4.411

6.  1H and 13C NMR chemical shifts of 2-n-alkylamino-naphthalene-1,4-diones.

Authors:  Rishikesh Patil; Mahesh Jadhav; Sunita Salunke-Gawali; Dipali N Lande; Shridhar P Gejji; Debamitra Chakravarty
Journal:  Heliyon       Date:  2021-01-28

7.  Development of long-circulating lapachol nanoparticles: formation, characterization, pharmacokinetics, distribution and cytotoxicity.

Authors:  Qunying Chen; Lu Bai; Xuelin Zhou; Pingxiang Xu; Xiaorong Li; Huanli Xu; Yuanyuan Zheng; Yuming Zhao; Shousi Lu; Ming Xue
Journal:  RSC Adv       Date:  2020-08-14       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.